Quality of Life After Open or Robotic Prostatectomy, Cryoablation or Brachytherapy for Localized Prostate Cancer
is accompanied by
Abstract
Purpose:
Health related quality of life concerns factor prominently in prostate cancer management. We describe health related quality of life impact and recovery profiles of 4 commonly used operative treatments for localized prostate cancer.
Materials and Methods:
Beginning in February 2000 all patients treated with open radical prostatectomy, robot assisted laparoscopic prostatectomy, brachytherapy or cryotherapy were asked to complete the UCLA-PCI questionnaire before treatment, and at 3, 6, 12, 18, 24, 30 and 36 months after treatment. Outcomes were compared across treatment types with statistical analysis using univariate and multivariate models.
Results:
A total of 785 patients treated between February 2000 and December 2008 were included in the analysis with a mean followup of 24 months. All health related quality of life domains were adversely affected by all treatments and recovery profiles varied significantly by treatment type. Overall urinary function and bother outcomes scored significantly higher after brachytherapy and cryotherapy compared to open radical prostatectomy and robotic assisted laparoscopic radical prostatectomy. Brachytherapy and cryotherapy had a 3-fold higher rate of return to baseline urinary function compared to open radical prostatectomy and robotic assisted laparoscopic radical prostatectomy. Sexual function and bother scores were highest after brachytherapy, with a 5-fold higher rate of return to baseline function compared to cryotherapy, open radical prostatectomy and robotic assisted laparoscopic radical prostatectomy. All 4 treatments were associated with relatively transient and less pronounced impact on bowel function and bother.
Conclusions:
In a study of sequential health related quality of life assessments brachytherapy and cryotherapy were associated with higher urinary function and bother scores compared to open radical prostatectomy and da Vinci® prostatectomy. Brachytherapy was associated with higher sexual function and bother scores compared to open radical prostatectomy, robotic assisted laparoscopic radical prostatectomy and cryotherapy.
References
- 1 : Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA1998; 280: 969. Google Scholar
- 2 : Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology2008; 71: 515. Google Scholar
- 3 : Evolution of robotic radical prostatectomy: assessment after 2766 procedures. Cancer2007; 110: 1951. Google Scholar
- 4 : Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol2003; 21: 3979. Google Scholar
- 5 : Erectile functioning of men treated for prostate carcinoma. Cancer1997; 79: 538. Google Scholar
- 6 : Quality-of-life outcomes in men treated for localized prostate cancer. JAMA1995; 273: 129. Google Scholar
- 7 : Patient-reported complications and follow-up treatment after radical prostatectomy: The National Medicare Experience: 1988-1990 (updated June 1993). Urology1993; 42: 622. Google Scholar
- 8 : Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst1997; 89: 1117. Google Scholar
- 9 : The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care1998; 36: 1002. Google Scholar
- 10 : Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer2007; 109: 2239. Google Scholar
- 11 : Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol2008; 180: 2415. Link, Google Scholar
- 12 : Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol2007; 21: 1521. Google Scholar
- 13 : Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer. J Endourol2005; 19: 318. Google Scholar
- 14 : Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med2008; 358: 1250. Google Scholar
- 15 : Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst2000; 92: 1582. Google Scholar
- 16 : Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology2002; 60: 3. Google Scholar
- 17 : Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology2001; 57: 518. Google Scholar
- 18 : Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology2002; 60: 645. Google Scholar
- 19 : The evolution and state of modern technology for prostate cryosurgery. Urology2002; 60: 26. Google Scholar
- 20 : Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques. J Urol2005; 174: 2291. Link, Google Scholar
- 21 : Robotic radical prostatectomy in the community setting–the learning curve and beyond: initial 200 cases. J Urol2005; 174: 269. Link, Google Scholar
- 22 : Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol2002; 20: 557. Google Scholar
- 23 : Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology2007; 69: 306. Google Scholar
